BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 15694322)

  • 1. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration.
    Shao Z; Browning JL; Lee X; Scott ML; Shulga-Morskaya S; Allaire N; Thill G; Levesque M; Sah D; McCoy JM; Murray B; Jung V; Pepinsky RB; Mi S
    Neuron; 2005 Feb; 45(3):353-9. PubMed ID: 15694322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors.
    Park JB; Yiu G; Kaneko S; Wang J; Chang J; He XL; Garcia KC; He Z
    Neuron; 2005 Feb; 45(3):345-51. PubMed ID: 15694321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.
    Mi S; Lee X; Shao Z; Thill G; Ji B; Relton J; Levesque M; Allaire N; Perrin S; Sands B; Crowell T; Cate RL; McCoy JM; Pepinsky RB
    Nat Neurosci; 2004 Mar; 7(3):221-8. PubMed ID: 14966521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Troy/Taj and its role in CNS axon regeneration.
    Mi S
    Cytokine Growth Factor Rev; 2008; 19(3-4):245-51. PubMed ID: 18524667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axon regeneration: it's getting crowded at the gates of TROY.
    Mandemakers WJ; Barres BA
    Curr Biol; 2005 Apr; 15(8):R302-5. PubMed ID: 15854897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp.
    Wang KC; Kim JA; Sivasankaran R; Segal R; He Z
    Nature; 2002 Nov; 420(6911):74-8. PubMed ID: 12422217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Nogo-66 receptor: focusing myelin inhibition of axon regeneration.
    McGee AW; Strittmatter SM
    Trends Neurosci; 2003 Apr; 26(4):193-8. PubMed ID: 12689770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dissection of the myelin-associated glycoprotein receptor complex reveals cell type-specific mechanisms for neurite outgrowth inhibition.
    Venkatesh K; Chivatakarn O; Sheu SS; Giger RJ
    J Cell Biol; 2007 May; 177(3):393-9. PubMed ID: 17470639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural features of the Nogo receptor signaling complexes at the neuron/myelin interface.
    Saha N; Kolev M; Nikolov DB
    Neurosci Res; 2014 Oct; 87():1-7. PubMed ID: 24956133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Soluble Form of LOTUS inhibits Nogo Receptor-Mediated Signaling by Interfering with the Interaction Between Nogo Receptor Type 1 and p75 Neurotrophin Receptor.
    Kawakami Y; Kurihara Y; Saito Y; Fujita Y; Yamashita T; Takei K
    J Neurosci; 2018 Mar; 38(10):2589-2604. PubMed ID: 29440387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Nogo receptor complex: confining molecules to molecular mechanisms.
    Schwab JM; Tuli SK; Failli V
    Trends Mol Med; 2006 Jul; 12(7):293-7. PubMed ID: 16723274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth.
    Wang KC; Koprivica V; Kim JA; Sivasankaran R; Guo Y; Neve RL; He Z
    Nature; 2002 Jun; 417(6892):941-4. PubMed ID: 12068310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ganglioside mediate the interaction between Nogo receptor 1 and LINGO-1.
    Saha N; Kolev MV; Semavina M; Himanen J; Nikolov DB
    Biochem Biophys Res Commun; 2011 Sep; 413(1):92-7. PubMed ID: 21872576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1.
    Niederöst B; Oertle T; Fritsche J; McKinney RA; Bandtlow CE
    J Neurosci; 2002 Dec; 22(23):10368-76. PubMed ID: 12451136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growth via p75NTR/NgR-independent pathways that converge at RhoA.
    Schweigreiter R; Walmsley AR; Niederöst B; Zimmermann DR; Oertle T; Casademunt E; Frentzel S; Dechant G; Mir A; Bandtlow CE
    Mol Cell Neurosci; 2004 Oct; 27(2):163-74. PubMed ID: 15485772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor.
    Liu BP; Fournier A; GrandPré T; Strittmatter SM
    Science; 2002 Aug; 297(5584):1190-3. PubMed ID: 12089450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems.
    Giger RJ; Venkatesh K; Chivatakarn O; Raiker SJ; Robak L; Hofer T; Lee H; Rader C
    Restor Neurol Neurosci; 2008; 26(2-3):97-115. PubMed ID: 18820405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelin-associated glycoprotein modulates apoptosis of motoneurons during early postnatal development via NgR/p75(NTR) receptor-mediated activation of RhoA signaling pathways.
    Palandri A; Salvador VR; Wojnacki J; Vivinetto AL; Schnaar RL; Lopez PH
    Cell Death Dis; 2015 Sep; 6(9):e1876. PubMed ID: 26335717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TROY interacts with Rho guanine nucleotide dissociation inhibitor α (RhoGDIα) to mediate Nogo-induced inhibition of neurite outgrowth.
    Lu Y; Liu X; Zhou J; Huang A; Zhou J; He C
    J Biol Chem; 2013 Nov; 288(47):34276-34286. PubMed ID: 24129566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein.
    Venkatesh K; Chivatakarn O; Lee H; Joshi PS; Kantor DB; Newman BA; Mage R; Rader C; Giger RJ
    J Neurosci; 2005 Jan; 25(4):808-22. PubMed ID: 15673660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.